Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Hainaut

Showing results (1-10 of 280) with videos related to

Pageof 28
Sort By:
Current Opinion in Oncology|February 4, 2022
Editorial: Chromatin dynamics and immunosurveillance - two sides of the cancer 'cell identity crisis'Pierre Hainaut
Nature Medicine|January 12, 2002
Tumor-specific mutations in p53: the acid testPierre Hainaut
Current Opinion in Oncology|February 16, 2011
Biomarkers in cancer research and treatment: promises and challengesPierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|November 26, 2010
Proteomics beyond proteomics: toward clinical applicationsAmelie Plymoth, Pierre Hainaut
Molecular Oncology|April 23, 2009
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosisZdenko Herceg, Pierre Hainaut
Cell Cycle (Georgetown, Tex.)|March 2, 2011
Pharmacological rescue of p53 in cancer cells: the soloist meets the PRIMA donnaHind Hafsi, Pierre Hainaut
Oncogene|March 8, 2005
Aminothiol WR1065 induces differential gene expression in the presence of wild-type p53Kristine Mann, Pierre Hainaut
Current Opinion in Oncology|November 25, 2015
Editorial: from cancer genotypes to phenotypes: a never-ending complexityPierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|February 6, 2020
Editorial: Dissecting the pathological bone marrow niche through single-cell omics and artificial intelligenceSophie Park, Pierre Hainaut
Current Opinion in Oncology|November 23, 2016
More chinks in the armor of cancer: potential for new therapiesPierre Hainaut, Amelie Plymoth
Pageof 28

Showing results (1-10 of 280) with videos related to

Sort By:
Pageof 28
Current Opinion in Oncology|February 4, 2022
Editorial: Chromatin dynamics and immunosurveillance - two sides of the cancer 'cell identity crisis'Pierre Hainaut
Nature Medicine|January 12, 2002
Tumor-specific mutations in p53: the acid testPierre Hainaut
Current Opinion in Oncology|February 16, 2011
Biomarkers in cancer research and treatment: promises and challengesPierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|November 26, 2010
Proteomics beyond proteomics: toward clinical applicationsAmelie Plymoth, Pierre Hainaut
Molecular Oncology|April 23, 2009
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosisZdenko Herceg, Pierre Hainaut
Cell Cycle (Georgetown, Tex.)|March 2, 2011
Pharmacological rescue of p53 in cancer cells: the soloist meets the PRIMA donnaHind Hafsi, Pierre Hainaut
Oncogene|March 8, 2005
Aminothiol WR1065 induces differential gene expression in the presence of wild-type p53Kristine Mann, Pierre Hainaut
Current Opinion in Oncology|November 25, 2015
Editorial: from cancer genotypes to phenotypes: a never-ending complexityPierre Hainaut, Amelie Plymoth
Current Opinion in Oncology|February 6, 2020
Editorial: Dissecting the pathological bone marrow niche through single-cell omics and artificial intelligenceSophie Park, Pierre Hainaut
Current Opinion in Oncology|November 23, 2016
More chinks in the armor of cancer: potential for new therapiesPierre Hainaut, Amelie Plymoth
Pageof 28